Evidence map›Paper›PMID 26313752›Full record

ArticlePloS one2015

Can We Predict Oral Antibiotic Treatment Failure in Children with Fast-Breathing Pneumonia Managed at the Community Level? A Prospective Cohort Study in Malawi.

Carina King, Eric D McCollum, Limangeni Mankhambo, Tim Colbourn, James Beard, Debbie C Hay Burgess, Anthony Costello, Rasa Izadnegahdar, Raza Izadnegahdar, Norman Lufesi and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Carina KingInstitute for Global Health, University College London, London, United Kingdom.
Eric D McCollumInstitute for Global Health, University College London, London, United Kingdom; Department of Pediatrics, Division of Pulmonology, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Limangeni MankhamboParent and Child Health Initiative, Lilongwe, Malawi.
Tim ColbournInstitute for Global Health, University College London, London, United Kingdom.
James BeardInstitute for Global Health, University College London, London, United Kingdom.
Debbie C Hay BurgessBill & Melinda Gates Foundation, Seattle, Washington, United States of America.
Anthony CostelloInstitute for Global Health, University College London, London, United Kingdom.
Rasa Izadnegahdar
Raza IzadnegahdarBill & Melinda Gates Foundation, Seattle, Washington, United States of America.
Norman LufesiAcute Respiratory Infection Unit, Ministry of Health, Lilongwe, Malawi.
Gibson MasacheParent and Child Health Initiative, Lilongwe, Malawi.
Charles MwansamboMinistry of Health, Lilongwe, Malawi.
Bejoy NambiarInstitute for Global Health, University College London, London, United Kingdom.
Eric JohnsonCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, United States of America.
Robert PlattMcGill University, Montreal, Canada.
David MukangaBill & Melinda Gates Foundation, Seattle, Washington, United States of America.
University College London · GBBill & Melinda Gates Foundation · USMinistry of Health · MWPublic Health Institute of Malawi · MWJohns Hopkins University · USKaiser Permanente Center for Health Research · USMcGill University · CA

Funding

Multidisciplinary Training Program in Pediatric PulmonaryT32HL072748 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Joseph Michael Collaco · 2003 to 2026
$6.1M
NHLBI NIH HHS T32 HL072748NHLBI NIH HHS T32 HL072748-11
6 · The paper itself

Abstract

backgroundPneumonia is the leading cause of infectious death amongst children globally, with the highest burden in Africa. Early identification of children at risk of treatment failure in the community and prompt referral could lower mortality. A number of clinical markers have been independently associated with oral antibiotic failure in childhood pneumonia. This study aimed to develop a prognostic model for fast-breathing pneumonia treatment failure in sub-Saharan Africa.

methodWe prospectively followed a cohort of children (2-59 months), diagnosed by community health workers with fast-breathing pneumonia using World Health Organisation (WHO) integrated community case management guidelines. Cases were followed at days 5 and 14 by study data collectors, who assessed a range of pre-determined clinical features for treatment outcome. We built the prognostic model using eight pre-defined parameters, using multivariable logistic regression, validated through bootstrapping.

resultsWe assessed 1,542 cases of which 769 were included (32% ineligible; 19% defaulted). The treatment failure rate was 15% at day 5 and relapse was 4% at day 14. Concurrent malaria diagnosis (OR: 1.62; 95% CI: 1.06, 2.47) and moderate malnutrition (OR: 1.88; 95% CI: 1.09, 3.26) were associated with treatment failure. The model demonstrated poor calibration and discrimination (c-statistic: 0.56).

conclusionThis study suggests that it may be difficult to create a pragmatic community-level prognostic child pneumonia tool based solely on clinical markers and pulse oximetry in an HIV and malaria endemic setting. Further work is needed to identify more accurate and reliable referral algorithms that remain feasible for use by community health workers.

Indexed as

Models, BiologicalAdministration, OralAnti-Bacterial AgentsChild, PreschoolCohort StudiesCommunity Health WorkersHumansInfantMalawiPatient CompliancePneumoniaProspective StudiesRespirationTreatment FailureTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID26313752
PMCPMC4551481
OpenAlexW1895481656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.